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The Effects of Ageing Population on Health Expenditure and 








The increasing proportion of the population aged 65 or over has generated a global rise 
of health spending due to higher demand for medical and long-term care services, which 
has become a growing challenge to the sustainability of public finances across countries. 
This phenomenon is especially prominent in China, which has experienced accelerated 
rates of both economic growth and population ageing over the past four decades. Using 
Bayesian-VAR (B-VAR) models we compute the impulse response functions (IRFs) and 
the forecast error variance decomposition functions (FEVDs) to empirically examine the 
dynamic relationships between ageing index, life expectancy, economic growth and 
health expenditure in China. We compare China with the USA which has distinct 
trajectories of population structure and economic development to better understand the 
former’s dynamic patterns. We find a pronounced response for both the USA and China 
of ageing index to life expectancy and of health spending per capita to GDP per capita, 
while ageing population induces a relatively strong reaction from health expenditure per 
capita in China. Our results are robust with either nominal or real variables. These 
findings suggest that, in China, a well-rounded policy accommodating economic, social 
and health factors is needed to improve the quality of life of the ageing population for a 
sustainable development of the economy. 
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Health expenditure plays an important role in people’s wellness and in countries’ economic 
development (Fogel 2002; 2004). In both developed and developing countries, health expenditure is 
highly and positively correlated with economic growth (Wang 2011; Braedle et al. 2016; Murthy et 
al. 2016; Lopreite and Mauro 2017). In particular, economic growth leads to increases in demand for 
medical services. Subsequent increases in life expectancy in turn lead to greater health expenditure 
(Werblow et al. 2007; Harper 2014). Moreover, large elderly cohorts have led to increased incidence 
rates of chronic diseases (i.e. cardiovascular diseases, cancer, chronic renal disease, diabetes and their 
respective complications) and higher demand of long-term healthcare services including expensive 
technologies and hospitalisation which has put the sustainability of healthcare systems at risk (Fujino 
1987; Murthy and Ukpolo 1994; Feng et al. 2020). On the other hand, greater health expenditure 
leads to increased availability of medical products and long-term healthcare services with a parallel 
rise of longevity (Kunze 2014). The resulted labour force with improved health status positively 
affects labour quality and labour productivity and therefore drives economic development and growth 
(Linden et al. 2017; Alvarez-Galvez et al. 2018). 
In recent decades, major developing economies such as China have experienced a substantial 
demographic transition due to both declines in fertility and increases in life expectancy. Compared 
with developed countries such as the USA that has had decades to adjust gradually its health spending 
to its ageing population, China’s ageing process started at an earlier stage of development and it was 
faster. 
In China from 1978-2017 the share of population aged 65 or over increased from 4.45 percent to 
10.64 percent with a significant impact on health spending and economic growth (Fougere et al. 1999; 
Bloom et al. 2015; Choi et al. 2015; Uddin et al. 2016). In the same period other indicators such as 
fertility rate declined from 2.9 percent to 1.6 percent and life expectancy increased from 65 to 76, 
both in consequence of China’s one-child policy further amplifying the negative effect of population 
ageing on health expenditure. 
In fact, the rapid fertility reduction associated with the one-child policy in China may have a negative 
impact on the elderly, as they might no longer be able to receive support from their children. 
Furthermore, the demographic shift may move China from a global source of low-cost workers to an 
economy suffering healthy labour shortages as the country approaches its Lewis Turning point from 
2020-2030 (IMF 2013). It is expected that China will become the world’s most aged society in 2050 
with the percentage of Chinese population above the retirement age projected to be almost tripled 
from 9.6 in 2015 to 27.6 in 2050. At the same time the elderly dependency ratio is expected to increase 
from 0.13 to 0.47 (UNPD 2015a). The old pension programmes in China penalise working in old age 
and encourage early retirement whereas population ageing makes it necessary to prolong the working 
lives to compensate for the increasing public eldercare costs. China will have proportionally smaller 
working-age population and a surge of retirees that will soon prompt questions on its ability of 
providing eldercare. The challenges of maintaining the sustainability of public finances and of 
managing the shortage of labour supply are thus driving the Chinese government to reform its 
retirement systems (UNPD 2015b). These effects will impose several constraints on China’s 
economic development and China could quickly lose its competitive edge to other emerging 
economies such as India and Indonesia, which increases its risk of falling into the “middle income-
trap” (Cai, 2012). 
According to China’s National Bureau of Statistics (2015) there were on average 27 beds in elderly 
care institutions per 1000 senior citizens in China in 2015, while there were respectively 37 beds in 
the USA and 55 in Germany (OECD 2017). In addition, the recent slowdown in China’s economic 
growth may reduce its health spending, with negative consequences on the quality of healthcare as 
well as on life expectancy.  
These observations suggest that China needs to readjust its policies in order to provide additional 
resources to the elderly and their households and to break the intergenerational cycle of poverty. To 
achieve these goals, it is crucial for the policymakers to understand the relationships between health 
spending, ageing, life expectancy and economic growth in China.  
The aim of this paper is to test these relationships empirically using the Bayesian vector 
autoregression (Bayesian-VAR or B-VAR) econometric techniques. The results will help 
policymakers better understand the dynamic interactions between the rapid growth of the older 
segment of the population in China and its healthcare and economic systems which are still far from 
adequately supporting the elder boom.   
The remainder of the paper is organised as follows. In Section 2 we present a summary of literature 
review and highlight our contributions. We pay particular attention to the studies exploring the 
empirical causal relationships between health spending per capita, GDP per capita, life expectancy 
and population ageing. In Section 3 we introduce the Bayesian VAR methodology and explain why 
it fits well with the aims of our study. In Section 4 we describe the data used in our empirical analysis. 
In Section 5 we show the results of the impulse response functions (IRFs) and the forecast error 
variance decomposition functions (FEVDs) and compare China with the USA for the same period of 
time. In Section 6 we evaluate the forecast accuracy of the frequentist VAR model and that of the B-
VAR model with different prior specifications (e.g. Minnesota prior versus Normal-inverse-Wishart 
prior). Finally, in Section 7 we test the robustness of the results by repeating the analysis for the same 
period of time with real GDP per capita and real health expenditure per capita before we conclude 
the paper. 
 
2. Literature Review 
 
We have performed a critical review of the literature that explores empirical relationships between 
the four variables, health expenditure, population ageing, life expectancy and economic growth.   
We use generally acknowledged databases such as Scopus, Google Scholar and PubMed. The search 
terms (i.e. key variables) employed in identifying the relevant literature include: “ageing (OR 
longevity) AND health expenditure (OR health spending OR cost) AND economic growth (OR GDP) 
AND life expectancy”.  
The above four variables are interrelated with each other. The relationship between life expectancy 
and population ageing is a straightforward one as the latter is driven by increases in the former 
combined with declines in fertility rates.  The empirical studies collected from our search strategy 
typically focus on one relationship (between a pair of variables) at a time. Therefore three strands of 
literature are summarised below depending on which of the three pairwise relationships between the 
three variables, health expenditure, population ageing (or life expectancy) and economic growth, is 
investigated.  
Firstly, we focus on the studies that assess the causal relationship between health spending and 
economic growth while grouping them in terms of one-way or two-way causality relations.  
Several studies analysing the one-way relationship between health spending and economic growth 
have stressed the importance of economic growth in health expenditure. For instance, Gerdtham et 
al. (2010) reveal that GDP per capita contributes significantly to the explanation of the health care 
expenditure’s variation between the 19 OECD countries. Braendle and Colombier (2016) show that 
income per capita is positively related to health care expenditure growth. Baltagi and Moscone (2010) 
using the data of 20 OECD countries over the period 1971-2004 demonstrate that health expenditure 
is a necessity rather than a luxury.  
Other studies, instead, have found a two-way causal relationship between health expenditure and 
economic growth. For instance, Wang (2011) analyses the data of 31 countries from 1986 to 2007 to 
explore the causality between an increase in healthcare expenditure and economic growth. He finds 
that health care expenditure growth stimulates economic growth whereas economic growth reduces 
expenditure growth. The findings of Amiri and Ventelou (2012) indicate that there exists a 
bidirectional Granger causality between GDP and healthcare expenditure in OECD countries. Amiri 
and Linden (2016) using the sample of 22 OECD countries find during the period 1970-2012 that 
a bilateral relationship between GDP and aggregate healthcare spending is widely predominant in the 
vast majority of OECD countries. Halici-Tuluce et al. (2016) show that a reciprocal relationship exists 
between health spending and economic growth in the short run for both low and high-income 
economies in their sample. Finally, Chaabouni et al. (2016) and Chaabouni et al. (2017) find a 
bidirectional relationship between health spending and economic growth for the period 1995-2013 in 
51 countries with low-middle or high income level. 
Secondly, the relationship between population ageing (or life expectancy) and health expenditure has 
also been studied in the literature. For example, Breyer and Felder (2006) find that the expanding of 
medical technology has a much larger impact on healthcare expenditure than ageing in Germany. 
Kildemoes et al. (2006) show that the population ageing in Denmark is likely to increase future 
expenditure on prescription drugs. Jaba et al. (2014) collecting the data for 175 countries obtain for 
the years 1995-2010 a significant relationship between health expenditure and life expectancy using 
a panel model. Murthy and Okunade (2016) using the annual data from 1960-2012 and the ARDL 
(autoregressive distributed lag cointegration) approach identify real income per capita, the share of 
population aged 65 or over and the level of health care technology as the major drivers of health 
expenditure per capita. Linden and Ray (2017) find a positive relationship between public health 
expenditure (in particular private expenditure) and life expectancy for 34 OECD countries between 
the years 1970 and 2012. Lopreite and Mauro (2016) using Bayesian-VAR (B-VAR) models show 
that health spending in Italy for 1990-2013 reacts more to ageing index than life expectancy and 
economic growth. Gallet and Doucouliagos (2017) using a meta-regression analysis find evidence of 
a greater effect on health spending of mortality rate compared to life expectancy. Obrizan and Wehby 
(2018) suggest that increasing health spending in countries with low life expectancy may have 
important returns to life expectancy. All in all, the existing literature investigating the relationships 
between health expenditure and its major drivers give different results which depend on data type 
(macro or micro) and on model specification. Moreover, the impact of several demographic changes 
(i.e. as number of people over a certain age, number of people with a given disabilities or chronic 
disease) on the health spending is still not clear and varies substantially.  
Finally, the relationship between population ageing and economic growth is also a reciprocal one as 
population age structure affects the pace of economic growth and economic performance leads to 
demographic changes as well. It has been well documented that an enlarged share of population in 
the working ages (i.e., an increase in the support ratio) generates the “first demographic dividend” in 
emerging Asia (Bloom and Williamson 1998, Lee et al. 2000). Mason and Lee (2006, 2007) further 
explores the possibility of a “second demographic dividend” through the accumulation of human and 
physical capital as more recently low fertility rates and high life expectancy lead to population ageing 
and a decline in the support ratio. Bloom et al. (2010a) have considered the economic impacts of 
population ageing through the lens of accounting, behavioural and institutional effects and their 
counterfactual exercises (assuming 2005-2050 growth rate of labour force per capita for 1960-2005) 
suggest modest declines of economic growth rates for OECD countries and an insignificant impact 
on the pace of economic growth in developing countries.    
Our contribution to the existing literature is at least twofold. Firstly, unlike the above-mentioned 
studies, we consider the relationships between health expenditure, ageing index, life expectancy and 
economic growth and investigate all the possible directions of causality. In order to do this, we use 
the Bayesian-VAR (B-VAR) methodology, which is especially suitable for short samples as in our 
case and offers better results than a classical VAR model. Moreover, we estimate a B-VAR model 
based on the Minnesota prior specification, which incorporates useful belief information on the 
distributions of parameters. As a result, we are able to conduct both short and medium-run analyses 
by computing the impulse response functions (IRFs) and the forecast error variance decomposition 
functions (FEVDs) and evaluate the forecasting performance.  
Secondly, we conduct a comparative analysis between China and the USA which are characterised 
by significant differences in the dynamics of their economic development and population age 
structure. In fact, the USA has long been considered as an “ageing society” (Llotyd-Scherlock et al. 
2000; Bloom et al. 2010a) whereas China is characterised by “getting old before getting rich” (Qiao, 
2006). As shown in Figure A1 in the appendix, although China has achieved phenomenal economic 
growth over the past several decades, its income and health expenditure per capita is still far behind 
the levels in the USA. However, the rates of life expectancy and population ageing in China have 
clearly accelerated over the past two decades and will soon arrive at the same levels as in the USA. 
Therefore, a comparative analysis between China and the USA enables us to interpret the results in 
context. 
 
3. Methodology: Setting the Prior for the B-VAR Estimation 
 
Over the past several decades the VAR models have been largely used as standard tools in 
macroeconomic analysis and forecasting (Sims 1980, 1992; Christiano et al.1999). The popularity of 
VAR models is due not only to their simple formulation but to that they are very successful in 
capturing dynamic linear relationships between time series without imposing restrictions on 
parameters as in structural VAR models. However, they show several problems when the frequentist 
approach is applied to VAR estimation. Firstly, a typical VAR model works better with a small 
number of variables. Thus, we may have a risk of ‘overfitting’ in the case of a large number of 
parameters (risk present also with moderate size) as the number of unrestricted parameters that can 
be estimated is limited. Secondly, since the VAR models usually include a few variables they tend to 
be poor models in forecasting and in structural analysis for omitted variables bias (Christiano et 
al.1999; Giannone and Reichlin 2006). Finally, the VAR approach suffers from the loss of degree of 
freedom if the lag length increases and becomes too large. In this case we have large standard errors 
and then unstable point estimates.  
These problems are particularly relevant in our context, where, due to the lack of data, we can perform 
our analysis only on a short period of time (1978-2016). One of the advantages of the B-VAR 
approach is to overcome the problems associated with overfitting and the poor forecasting 
performance  introduced by the VAR methodology when the dataset is short, the sample information 
is weak or the number of the parameters is large (Litterman 1981, 1986; Sims 1982; Doan et al. 1984; 
Stock and Watson 2001; Canova 2007; Banbura et al. 2010; Auer 2014; Kanngiesser et al. 2019). 
The Bayesian inference using the parameter shrinkage, which we describe below, improves the 
dynamic analysis and forecasting accuracy of the models. 
Specifically, it is possible to reduce the estimation error and to have only a small bias on the 
parameters for the restrictions (priors) on the coefficients assuming that they are more likely close to 
zero with respect to the coefficients of the shorter lags (Litterman 1981, 1986; Doan et al. 1984).  
The use of the B-VAR, with the help of the priors as the key factor, makes additional knowledge 
available during the estimation and hence achieves better results without the need of requiring 
restricted models (i.e. models with many coefficients set to zero). Specifically, the Bayesian approach 
combines the sample information with the researchers’ prior information on the coefficients (priors) 
to derive a posterior distribution. The choice of the prior is an important step of the Bayesian inference 
since if the prior is too loose, overfitting is hard to avoid; conversely if it is too tight, the data are not 
allowed to speak. The researchers set the prior according to the information they have on the nature 
of the parameters of interest or they may use informative priors to reflect their beliefs. 
The specification of the priors allows to solve two problems: (a) equations with too many free 
parameters tend to pick up excess noise, and (b) equations with too few parameters fail to pick up the 
signal. The usage of the priors provides a flexible solution to the trade-off between less overfitting 
data and more signal extraction capabilities. Moreover, many studies (Bambura et al 2010; Auer 
2014) have confirmed that the B-VAR methodology can be used with success for large datasets as 
well as for datasets with a moderate level of cointegration. 
The Bayesian methods use the maximum likelihood function to estimate the posterior probabilities. 
This function in other domains can overcome limitations of the techniques such as the generalized 
method of moments (GMM) of Arellano and Bond (1991). Following Allison et al. (2017) the 
maximum likelihood function changes how the structural estimation models (SEM) perform, 
allowing accurate estimations. 
In the rest of this section we introduce the Litterman-Minnesota prior (Litterman 1986) and the 
Normal Inverse Wishart prior used in our study.  
We start from a standard VAR(𝑞) model: 
    𝑌𝑡 = 𝑐 + 𝐴1𝑌𝑡−1 + 𝐴2𝑌𝑡−2+. . … . +𝐴𝑞𝑌𝑡−𝑞 + 𝑢𝑡                                 (1)                                                                                                                                                                          
Where 𝑞 is the maximum lags, 𝑐 are any constant variables in the model, 𝑌𝑡 is a vector of the 
endogenous variables (𝑁), 𝐴 are the regression coefficients in matrix form (𝑁 × 𝑁) and 𝑢𝑡is the white 
noise error term with a covariance matrix 𝐸(𝑢𝑡𝑢𝑡
′ ) = 𝜓.  
We can rewrite the VAR equation (1) as a system of multivariate regressions:  
                             𝑌 = 𝑋𝐴 + 𝑈                                                                                                                (2) 
Where: 
(a) 𝑌𝑡 = (𝑦1, … … … . , 𝑦𝑇)
′. The matrix dimension is 𝑇 × 𝑁 (number of observations×each 
dependent variable). 
(b) 𝑋 = (𝑥1, … … … . , 𝑥𝑇)
′ with 𝑋𝑡 = (1, 𝑦𝑡−1
′ , … … … . , 𝑦𝑡−𝑞
′ )′.The matrix dimension is 𝑇 × 𝑘 
where 𝑘 = 𝑁𝑃 + 1. (number of observations ×each lagged dependent variable).  
(c) 𝐴 = (𝑐, 𝐴1 … … … . , 𝐴𝑞)
′. The matrix dimension is 𝑘 × 𝑁 (number of constant/autoregressive 
terms×each lagged dependent variable). 
(d) 𝑈 = (𝑢1, … … … . , 𝑢𝑇)
′ collects the error terms. The dimension is 𝑇 × 𝑁 (number of error 
terms×each dependent variable). 
By applying the Bayesian method to VAR models it is possible to select the priors combined with the 
likelihood function and to produce a tractable posterior that has generally the same density function 
of the prior. 
In our case the Litterman/Minnesota prior for 𝛽 (the parameter of our interest) is a priori normal 
conditional upon the variance-covariance matrix ∑𝑒. Specifically, the Litterman/Minnesota prior 
assumes that the prior means of 𝛽 are all the same given by the value of the hyperparameter 𝜇  is set 
close to zero, while the covariance prior is non-zero. However, in some cases 𝜇 is set close to one in 
order to capture the persistence of the time series.  
Then, the first step is to define the nature of the matrix ∑𝑒and replace it with an estimate ∑?̂? . In 
general we have three options to set this matrix: (a) using for each series the estimate of the residual 
variances by fitting AR(1) models; (b) assuming the variance-covariance matrix to be diagonal where 
all coefficients, except their own lags (and a possible constant), are equal to zero. This is the more 
used option as it yields a significant decrease of the computational burden for no relationship among 
the coefficients of the model’s equations; (c) estimating ∑𝑒 from a classical VAR model. In general, 
this last choice is not used because if the number of variables and of lags is large, and we have not 
enough observations, the variance-covariance matrix might be singular. 
After defining the nature of the variance-covariance matrix ∑𝑒 (fixed, diagonal and known) we need 
to specify the prior covariance for 𝛽  considering a set of hyperparameters.  
Given a diagonal variance-covariance matrix we select the hyperparameters by specifying four 
scalars: 
(a) 𝜆1 controls the relative importance of sample and prior information. It represents the overall 
tightness on the variance of the first lag. Setting 𝜆1 to a small value implies that the prior 
information dominates the sample information. On the contrary if 𝜆1 → ∞, the prior becomes 
non-informative and the posterior estimates converge to the unrestricted VAR coefficients. 
(b) 𝜆2 sets the relative importance for the lags of the other variables (i.e. lagged variable 𝑖-th in 
𝑗-th equation with 𝑖 ≠ 𝑗).  
(c) 𝜆3 regulates the relative importance of the information contained in the exogenous variables 
(i.e. a constant). 
(d) 𝜆4 captures the lag decay and it takes into account the different scale and variability of the 
data. Setting 𝜆4 equal to 1 implies a linear decay while if we set greater than zero we have 
two functional forms: harmonic or geometric decay.  
Once the prior covariance is set, the posterior of 𝛽 will also be normal. In particular the mode and the 
mean will correspond to a normal. 
Although the Litterman/Minnesota is actively used for its success in forecasting, it ignores any 
uncertainty associated with the variance-covariance matrix. The Normal Inverse Wishart prior relaxes 
the assumption of a fixed and diagonal variance-covariance matrix of the error terms, therefore 
overcoming the two main weaknesses in the Litterman prior: the posterior independence between 
equations and the fixed residual variance-covariance matrix. 
Moreover, it is easy to interpret and to calculate, since, the posterior distribution follows the same 
parametric form of the prior distribution and therefore the prior information can be interpreted in the 
same way as the likelihood function information.  
The Normal-Wishart prior represents a natural conjugate prior for the variance-covariance matrix 
∑𝑒that with a prior of 𝛽 set to a normal result in a posterior for 𝛽 equal to the product of a Normal 
and a Wishart distribution. In this case the prior of 𝛽 depends on the prior means of 𝛽 matrix terms 
and ∑𝑒 . For ∑𝑒 we select the hyperparameter 𝜆1that works in the same way of the Minnesota prior. 
Moreover, we need to select the two parameters 𝑣 and 𝑆 that are respectively the degrees of freedom 




Our dataset contains the following annual macro-variables: nominal gross domestic product  per 
capita (GDPN) as an economic indicator,  nominal health expenditure per capita (HEX) as healthcare 
indicator, life expectancy (LFE) and ageing index (AI) as demographic and health indicators.  
Following Lopreite and Mauro (2017) we compute ageing index (AI) as the ratio between the number 
of people aged 65 or over and the number of people aged from 0-14. Since the numerator (the size of 
elderly population is increasing) and the denominator (the size of young population is decreasing due 
to declines in fertility) of AI vary in the opposite direction, the overall indicator rises over time. Life 
expectancy (LFE) is also a relevant indicator that reflects people’s health status as a result of their 
standard of living, lifestyle, education, way to eat, sport practice etc. According to the World Bank 
definition, life expectancy at birth is the average number of years a newborn is expected to live if 
mortality patterns at the time of its birth remain constant in the future. We use the total value (male 
plus female) of this indicator. 
Finally, we use nominal GDP as a measure of income, and nominal health expenditure as a measure 
of the consumption of healthcare products and services. Both indicators are expressed in per capita 
value.  
The sample spans from the year 1978 to the year 2016 due to data availability. Note that this period 
of time observed China’s rapid economic growth and demographical structure change since China’s 
economic reform of 1978. The data of nominal GDP per capita (GDPN), ageing index (AI), and life 
expectancy (LFE) are obtained for both China and the USA from the World Bank Development 
Indicators Database. The data of nominal health expenditure per capita (HEX) are extracted for the 
USA from the OECD database while for China are extracted from the China Statistical Yearbook. 
We convert nominal health expenditure per capita in China into US dollars using the RMB-dollar 
exchange rates contained in the China Statistical Yearbook. Finally, we apply the logarithms to 
GDPN and HEX in order to reduce the dimensional effects and to minimise the linearisation and the 
normalisation requirements. 
As we can see in Table 1 the USA shows a much higher average value of GDPN and of HEX while 
the difference between China and the USA in AI and LFE is not as significant. We also notice that 
the standard deviation of AI and of LFE is higher in China than in the USA.   
These findings suggest that, given the lower average values of the Chinese HEX and GDPN, AI and 
LFE may lead to more constraints on health spending and economic growth in China than in the USA.    
 
Table 1: Summary statistics 
 China USA 
 HEX LFE AI GDPN HEX LFE AI GDPN 
Mean 99.36 71.37 29.45 1943.6 4819.3 76.30 59.28 32893 
Median 31.26 70.75 24.66 781.75 4145 76.42 57.63 31573 
Max 504.49 76.25 57.19 8117.3 10410 78.84 78.99 57589 
Min 6.80 65.86 11.85 156.40 865 73.35 47.62 10587 
St. dev 141.62 3.16 13.80 2506.2 2931.6 1.71 6.7 14310 
 
5. B-VAR Analysis: Impulse Response Functions and Forecast Error Variance Decomposition 
Functions  
 
In this section we analyse the impulse response functions (IRFs) as well as the forecast error variance 
decomposition functions (FEVDs) based on the B-VAR model for China and compare the results 
with those for the USA.  
To this end, we estimate the B-VAR model with two lags selected according to the Schwartz Bayesian 
criterion. The model is specified by considering  nominal gross domestic product per capita (GDPN),  
nominal health expenditure per capita (HEX), life expectancy (LFE), ageing index (AI) and a 
constant. We select the four hyperparameters of the Minnesota prior covariance matrix as follows: 𝜆1 
(prior information) is set to a small value since the prior beliefs influence the estimation with respect 
to the information contained in the data; 𝜆2 (cross variables lags) and 𝜆3 (exogenous variables) are 
set greater than zero because the information of cross variable lags and of the exogenous variables is 
important for our analysis; 𝜆4 (lag decay) is set greater than zero since the variables are similar in 
their scale, we assume a geometric decay.  
The reasons why we apply the Minnesota prior specification are threefold: firstly, in our analysis we 
use series in levels and the Minnesota’s performance is optimal with this type of macro-variables; 
secondly, using the levels of the time series we can capture, by analysing the IRFs and the FEVDs, 
the dynamic information on the relations among the variables (in the short and  medium-run); thirdly 
we obtain estimation gains with respect to an unrestricted VAR since the Minnesota prior shrinks the 
estimated coefficients of the VAR model towards the prior mean and away from the OLS estimates. 
Figure 1 and Figure 2 depict the IRFs for the B-VAR model for China and the USA side by side for 
the four variables (GDPN, HEX, LFE, AI). The shaded regions indicate the posterior coverage 
intervals corresponding to the 95% of the Bayesian credible sets obtained through Gibbs sampling 
using 1000 iterations.  
  
Figure 1: B-VAR impulse response functions with 95% credible intervals for China and the USA side 





Figure 2: B-VAR impulse response functions with 95% credible intervals for China and the USA side 
by side for nominal gross domestic product per capita (GDPN) shock and health expenditure per 




We present the responses of a variable to a shock (one standard deviation) from each of the other 
variables for the B-VAR model until ten years when this effect becomes less significant. In particular 
we study whether there exist or not significant relationships between nominal gross domestic product 
per capita (GDPN),  nominal  health expenditure per capita (HEX), life expectancy (LFE) and ageing 
index (AI) and what the directions of causality are. As a robustness check, we also extend the horizon 
of the IRFs from ten to twenty years and the new IRFs for both China and USA converge to zero or 
to a constant level. This suggests the absence of explosive functions like exponential IRFs that do not 
converge to zero or constant levels given unstable causal relationships (see Figures A2 and A3 in the 
appendix).  
For China a LFE shock raises AI approximately of 0.5% after 2.5 years and it becomes not significant 
after 4 years (third row, first column, Figure 1). At the same time, AI has also a positive effect on 
GDPN that remains significant for the years 3-7 (with a peak around 1.2%  after 5 years) while on 
HEX the effect becomes significant after 5 years and it is increasing in the long run (with a peak 
around 2% after 7.5 years) (second row, first and third column, Figure 1). On the other hand, GDPN 
has a positive and significant impact on LFE (first row, third column, Figure 2), whereas its impact 
on HEX is only slightly positive and becomes not significant after 5 years (second row, third column, 
Figure 2). Finally, more HEX leads to an increase that is persistent in time for both LFE (by 0.8 after 
5 years) and AI (by 0.3 after 2.5 years) (third row, third and first column, Figure 2). To better 
understand the patterns found for China, we also estimate a B-VAR model for the USA for the same 
period of time as a comparison. We observe a significant and positive response that becomes 
persistent in the long term respectively from HEX to a GDPN shock (second row, fourth column, 
Figure 2), from LFE to AI (third row, second column, Figure 1) and from AI to an HEX shock (third 
row, second column, Figure 2). Moreover, we find a weakly negative effect only in the long run of 
an HEX shock on LFE (third row, fourth column, Figure 2). We also observe a positive and very 
weak long run effect of a GDPN shock on LFE (first row, fourth column, Figure 2). Finally, we 
observe a temporary and weak impact of AI on HEX: the short-lived effect becomes insignificant 
after 6 years (second row, fourth column, Figure 1). Unlike the finding for China, the effect of an AI 
shock on GDPN is not significant for the USA (second row, second column, Figure 1).  
To further understand the relative importance of each variable in affecting other variables, we 
compute the forecast error variance decomposition functions (FEVDs) for China and the USA side 
by side for the same time horizon of ten years (Figures 3 and 4), which confirm the robustness of the 
above results. Specifically, for China we find a moderate contribution of AI (around 2%) to the 
variance of GDPN (second row, first column, Figure 3). We also observe a significant impact of AI 
(around 3%) on HEX (second row, third column, Figure 3),  of GDPN (around 2.5%) on HEX (second 
row, third column, Figure 4) and of GDPN (around 75%) on LFE (first row, third column, Figure 4). 
On the other hand, for the USA GDPN has accounted for about 70% of HEX’s forecast error variance 
after 10 years (second row, fourth column, Figure 4). Moreover, we find a significant influence 
(around 30%) of LFE on AI (third row, second column, Figure 3) and of GDPN (around 60%) on AI 
(first row, second column, Figure 4). Finally, we observe a moderate contribution of AI (around 1%) 
to HEX’s variance (second row, fourth column, Figure 3).  
Figure 3: B-VAR forecast error variance decomposition functions with 95% credible intervals for 
China and the USA side by side for ageing index (AI) shock and life expectancy (LFE) shock (10-




Figure 4: B-VAR forecast error variance decomposition functions with 95% credible intervals for 
China and the USA side by side for  nominal gross domestic product per capita (GDPN) shock and 




The comparison between China and the USA can be summarised as follows. For China, LFE, GDPN 
and AI have relatively strong impacts on the other variables, whereas in the USA, HEX and GDPN 
are the major drivers, as shown in the IRFs results. This means that GDPN plays an important role in 
the macro systems for both countries. However, compared with the situation in China, in the USA, 
life expectancy (LFE) and ageing population (AI) have relatively small impacts on the other variables. 
In other words, these findings suggest that the increasing share of elderly population has a greater 
impact on China than to the USA.  
 
6. Forecast Evaluation 
 
To evaluate the performance of our model, in this section we empirically compare the forecast 
accuracy resulted from two different VAR specifications (unrestricted VAR model and B-VAR 
models based respectively on the Minnesota prior and on the Normal-inverse-Wishart prior) for our 
dataset of both China and the USA over the period 1978-2016. 
We compute the point forecasts (two year ahead) using the Root Mean Square Error (RMSE) and the 














where 𝑦𝑖 are the data and 𝑦?̅?is the forecast value of 𝑦𝑖. 
We prefer to use both measures because RMSE is more sensitive to large deviations from the true 
values while MAE is more sensitive to small deviations from the true values. 
A small value of RMSE, and of MAE suggests a good performance of the model. Table 2 presents 
the results for China and the USA. The findings show that the B-VAR models based on Minnesota 
prior fit better than the VAR model and the B-VAR model based on the Normal-inverse-Wishart 
prior. Overall, the prior information improves the forecast accuracy of the B-VAR models with 
respect to other specifications (VAR model).  
 
Table 2: A comparison between USA model and China model: Forecasting VAR vs B-VAR 
(nominal variables) 
 Variable RMSE MAE 
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7. Further Robustness Checks 
 
We further check the robustness of the results by repeating the analysis for the same time span (1978–
2016) and for both countries with real variables (i.e., real GDP per capita and real health expenditure 
per capita). To do so, we deflate the time series of nominal GDP per capita and nominal health 
expenditure per capita with constant prices in 2010 for both countries.  
A B-VAR model is therefore estimated to test the relations between real GDP per capita (GDPR), 
real health expenditure per capita (HEXR), aging index (AI) and life expectancy (LFE). The results 
remain qualitatively unchanged. In particular, the IRFs based on the B-VAR model with the horizon 
of twenty years yield a significant response for both the USA and China of AI to LFE and of HEXR 
to GDPR. As before, we also observe that AI has a stronger impact on HEXR and GDPR in China 
than in the USA (Figures 5-6). These relations are again confirmed by the results of FEVDs (Figures 
7-8).  
We also run diagnostics of the model with respect to the requirements of absence of serial 
autocorrelation, and structural stability of the parameters estimated (the results are available on 
request). The results obtained therefore confirm the analysis of the IRFs and the FEVDs of the B-
VAR model previously estimated with nominal variables. Finally, the forecast accuracy of the B-
VAR model is again the highest among all the specifications (Table A1 in the appendix). 
 
  
Figure 5: B-VAR impulse response functions with 95% credible intervals for China and the USA side 





Figure 6: B-VAR impulse response functions with 95% credible intervals for China and the USA side 
by side for real gross domestic product per capita (GDPR) shock and real health expenditure per 





Figure 7: B-VAR forecast error variance decomposition functions with 95% credible intervals for 
China and the USA side by side for ageing index (AI) shock and life expectancy (LFE) shock (20-




Figure 8: B-VAR forecast error variance decomposition functions with 95% credible intervals for 
China and the USA side by side for real gross domestic product per capita (GDPR) shock and real 




8. Conclusions and Policy Implications 
 
This paper empirically examines the relationships between ageing index, life expectancy, economic 
growth and health spending in China. We compute the impulse response functions (IRFs) and the 
forecast error variance decomposition functions (FEVDs) based on the Bayesian-VAR (B-VAR) 
model for China over the period 1978-2016. The B-VAR model is preferred over others for three 
reasons: (a) it is an appropriate choice for handling short time series data (i.e., with a small number 
of years); (b) it naturally incorporates judgmental information and a priori beliefs into the model 
settings; (c) it performs better in terms of forecasting accuracy than a classical VAR model. 
Unlike the existing literature where empirical relationships are examined one at a time, this paper 
considers the relationships between ageing index, life expectancy, economic growth and health 
spending and all the possible directions of causality simultaneously using standard B-VAR 
specifications. We set the priors following standard recommendations from the Bayesian literature 
and take into account the data characteristics. The results suggest that the Minnesota prior information 
is important for the dynamical analysis as well as for the forecasting accuracy. In particular, it 
produces better forecasting results than the VAR models or the B-VAR models based on Normal 
Inverse Wishart prior. 
Furthermore, with a comparison with the USA for the same period of time, we have found the 
following main results: (a) economic growth generally promotes health spending and an increase in 
life expectancy leads to an increase in ageing index in both China and the USA; (b) the importance 
of ageing index in health expenditure and in GDP is larger in China. These findings suggest that 
China is more affected by population ageing in the observation period from 1978-2016.  
Not only do China and the USA differ from each other in terms of the importance of AI measured by 
FEVDs, but the two countries also differ in the timing of AI-triggered GDPN and HEX responses 
measured by the IRFs. In particular, China has a positive medium-run significant impact of AI on 
GDPN whereas the impact for the USA is negative and insignificant. China has a positive and 
significant impact of AI on HEX in the long-run whereas the impact for the USA is also positive and 
significant but in the short-run.   
To make sure that our results are not driven by price factors during this period of time, we further 
check the robustness of the results by repeating the analysis with real GDP per capita and real health 
expenditure per capita. The results indeed remain qualitatively unchanged.  
Our results are in line with the predictions by Bloom et al. (2010a) in a sense that population ageing 
induces a more negative effect on economic growth for developed countries than for developing 
countries. However, there are notable differences between the decomposition analyses of the effects 
of population ageing on economic growth in the existing literature (Bloom et al. 2010a, 2010b, Mason 
and Lee, 2007) and ours. Firstly, the previous decomposition analyses are based on economic growth 
accounting (i.e., decomposing economic growth rates into demographic growth rates and others) 
whereas ours are based on an empirical model B-VAR and the related computation of FEVDs. The 
FEVDs show the amount of information that each variable contributes to the other variables in the 
model. It determines how much of the forecast error variance of each of the variables can be explained 
by exogenous shocks to the other variables. Our FEVDs analysis is useful to determine which of the 
independent variables is “stronger” in explaining the variability in the dependent variables over time. 
Secondly, rather than using counterfactual exercises or simulations, this paper is empirically driven 
by actual data and hence provides solid evidence of the different economic reactions to population 
ageing between the largest developing economy and the largest developed economy in the world. The 
differences observed above between China and the USA are clearly linked to the different dynamics 
of population age structure and economic development experienced in the past four decades by the 
two countries. The rapid growth of the proportion of the elderly has led China to “become old before 
getting rich” and to lose its “first demographic dividend” (Cai, 2010). On the contrary, the USA, as a 
developed country, has possessed a mature social and economic system while supporting its ageing 
population (see Figure A1 in the appendix). While an AI shock still triggers a positive and significant 
response from GDPN in China in the medium-run, it is unlikely to sustain in the coming decades 
given that China’s economic growth has already slowed down.  
On the other hand, the medium-run significant response of HEX to AI shocks is more worrisome for 
China. One way to cut the health expenditure in China is to establish a fully functioning three-tier 
healthcare system, where the role of primary healthcare providers as a gatekeeper is of critical 
importance (Li et al. 2017, Xu and Mills 2019, Yu 2015, Yip et al. 2019). Moreover, a sounding 
health infrastructure cannot live without sustainable financial schemes. In this regard, China has made 
promising progresses for both urban and rural populations (Hsiao 1995, Feng et al. 2020, Gao et al. 
2014). Another solution, as emphasised by Bloom et al. (2010a), is to encourage behavioural 
adjustments. For instance, community programmes can be developed to help the elderly maintain 
their economic activities by providing training and employment opportunities, flexible working hours 
and remuneration even after their retirement. More generally, a retirement reform  requires a 
comprehensive policy package effectively addressing a host of factors including replacement rate of 
pension, personal life events, savings, work condition, health, and family circumstances rather than 
merely postponing the retirement age (Liu and Sun, 2016).  
Resulted from an evidence-based approach, the findings presented here are clearly informative for 
supporting healthcare policy decisions. But to devise or evaluate a specific healthcare policy, it 
certainly requires detailed investigation, especially at micro level, as the aggregated variables 
considered here cannot be directly translated into policy instruments. Another limitation of this study 
is that only a short period of time from 1978-2016 and only two countries are considered here. The 
limitation can be addressed in the future with larger data sets with longer time series or more 
countries, which are desirable for further testing the robustness of the results and for generalising the 
policy implications for both developed and developing countries. These issues are left for future 
investigation.   
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Figure A2: B-VAR impulse response functions with 95% credible intervals of nominal gross domestic 
product per capita (GDPN), health expenditure per capita (HEX), life expectancy (LFE), ageing index 




Figure A3: B-VAR impulse response functions with 95% credible intervals of nominal gross domestic 
product per capita (GDPN), health expenditure per capita (HEX), life expectancy (LFE), ageing index 





Table A1: A comparison between USA model and China model: Forecasting VAR vs B-VAR 
(real variables) 
 Variable RMSE MAE 












































 Variable RMSE MAE 
China model    
Standard VAR 
 
LFE 
AI 
GDPR 
HEXR 
0.63 
0.93 
0.67 
0.53 
0.61 
0.89 
0.59 
0.57 
Minnesota prior 
 
LFE 
AI 
GDPR 
HEXR 
0.03 
0.06 
0.04 
0.03 
0.03 
0.04 
0.01 
0.01 
Normal-Wishart  
prior 
 
LFE 
AI 
GDPR 
HEXR 
0.20 
0.58 
0.27 
0.63 
0.17 
0.58 
0.39 
0.61 
 
 
 
 
